Aristides Capital’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,500
Closed -$199K 282
2024
Q4
$199K Buy
+14,500
New +$199K 0.04% 230